Halo Genomics has added MDxK as distributor of its sequencing target enrichment products in South Korea, the company said last week.
Halo Genomics, based in Uppsala, Sweden, offers sequencing target selection services and kits that are based on its Selector technology. It is currently working on a new product, the HaloPlex Target Enrichment kit, that combines single-tube target amplification and sequencing library prep for the Illumina platform (IS 3/1/2011).
The firm, which changed its name from Olink Genomics last year, recently signed on a number of other distributors: Westburg for Belgium, Luxembourg, and the Netherlands; Cambio for the UK; Integrated Sciences for Australia and New Zealand; and Biozym Scientific for Germany and Austria.
MdxK, founded in 2007 and based in Seoul, provides products and services for molecular research and diagnostics in South Korea.